Investor Relations

This section of the Co-Diagnostics InvestorRoom houses up to date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing. 

Please note:  All data in this section is provided by a 3rd party provider and may be delayed up to 20 minutes.  Co-Diagnosticsassumes no responsibility for the accuracy of this data and provides it for informational purposes only.

NASDAQCODX
Beta(0.52)
Shares Outstanding30.9M
Average Volume (10 days)104.4K
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)$0.47
Sales (TTM)$1.06
Book Value (MRQ)$4.36
Cash Flow (TTM)$0.48
Cash (MRQ)$2.76

Analyst Views

Current Mean RecommendationBuy
Strong Buy2
 
Buy0
 
Hold2
 
Underperform0
 
Sell0
 

Recent Insider Transactions

Richard S. Serbin
Director
12,500
Acquire
Jan 8, 2023
James Nelson
Director
12,500
Acquire
Jan 8, 2023
Eugene Durenard
Director
12,500
Acquire
Jan 8, 2023
Dwight H Egan
Director, Chief Executive Officer
(32,110)
Dispose
Nov 23, 2022
Brian L. Brown
Chief Financial Officer
(18,187)
Dispose
Nov 23, 2022

Recent SEC Filings

S-8
Jan 23, 2023
Insider Buy/Sell
Jan 19, 2023
Insider Buy/Sell
Jan 19, 2023
Insider Buy/Sell
Jan 19, 2023
Insider Buy/Sell
Jan 19, 2023